Latest News

Yale School of Medicine researchers explore the many functions of mitochondria—and how their malfunction can contribute to a broad range of diseases.

Researchers are uncovering the fundamental rules of immunology. It’s enabling them to better treat disease—and even predict it before it strikes.

People who got the injection, retatrutide, lost 28 percent of their body weight on average after 80 weeks, Eli Lilly said.

In a clinical trial, the new weight-loss medication retatrutide led to "clinically meaningful weight reduction," with the highest dose linked to a 30% reduction in average body weight.

Growing evidence from Yale suggests that regular physical activity can help lower cancer risk and improve outcomes. Experts emphasize that while exercise isn’t a cure-all, even moderate activity may offer meaningful benefits.

Before the new obesity drugs came on the market, almost no one used the term food noise. If researchers can clarify the source of this inner buzz and what makes it go away, that could lead to a clearer understanding of what causes obesity in the first place.

Generations of Yale physicians have treated patients and launched cutting-edge health care initiatives through Yale’s affiliation with the VA Connecticut Healthcare System.

The Yale Department of Internal Medicine recently presented its third Voluntary Faculty Awards, honoring voluntary faculty who teach medical students, physician associate students, residents, and fellows across Yale School of Medicine, Yale New Haven Hospital, Yale New Haven Health, and affiliated hospitals.